X4 Pharmaceuticals, Inc.

US$3.18As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:XFORHealthcare
Country USA
PE (Fwd) •••
TSR 8Y CAGR (48.85%)
Div yield —
ROE (80.32%)
Biotechnology
Beta (5Y) 0.47
PE TTM —
TSR TTM (21.29%)
Mkt cap US$324.7M
ROIC (275.59%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$3.68
15.62%
163.00%
Hold 1|1|1|3|8
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.07
0.08
0.07
0.08
15.30%
31.03%
27.62%
20.38%
Revenue$M
36.02
36.02
36.99
36.37
6.32%
0.73%
3.97%
1.84%
Peers (US$324.7M)
Cap (US$)
PE
323.5M
16.63x
Capital
TTM
5Y
10Y
Leveragex
2.297
(0.292)
(0.294)
EBIT/Intx
0.239
0.163
0.181
Own earn%
(311.00)
42.45
33.88
Sh yield%
48.63
42.56
36.28
Owners
Insiders/Inst%
13.10
81.65
Short interest%
2.74
SBC / revenue%
3.64
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
0–1
$1 testx
—
Incr. ROIC%
0